@BillMiller32 Avatar @BillMiller32 Bill Miller

Bill Miller posts on X about $xbi, $axsm, $ibb, $tgtx the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

Engagements: [--] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks 16.98% finance 16.04% currencies 6.6% cryptocurrencies 2.83% financial services 0.94% technology brands 0.94%

Social topic influence $xbi #38, $axsm 50%, $ibb #10, $tgtx 25.47%, $abbv 6.6%, $azn 6.6%, strong 5.66%, ada 5.66%, imo 4.72%, $itci 4.72%

Top accounts mentioned or mentioned by @biomaven @semodough @technicalair @cornel6m @biotech2050 @andrewedunn @joebaffoe @94vs @cantilloncap @shortshitstocks @7skiestech @jd4for4 @pharmdca @zipjet @geertlangenus @liquidbiopsy

Top assets mentioned Axsome Therapeutics, Inc (AXSM) TG Therapeutics, Inc. (TGTX) AbbVie Inc (ABBV) AstraZeneca PLC (AZN) Intra-Cellular Therapies Inc. (ITCI) Novartis AG (NVS) Novavax Inc (NVAX) Nuvectis Pharma, Inc. (NVCT) Basis Cash (BAC) Gilead Sciences, Inc. (GILD) Biogen Inc (BIIB) GSK plc (GSK) Pfizer, Inc. (PFE) Moderna Inc (MRNA) Vixco (VIX) Phemex Token (PT) Sage Therapeutics, Inc (SAGE) JPMorgan Chase (JPM)

Top Social Posts

Top posts by engagements in the last [--] hours

"RT @semodough: $TGTX very important slide for $TGTX why #MS patients need to be on CD20 - & sooner the better @Biomaven brought to my atten"
X Link 2025-08-29T19:41Z [----] followers, [--] engagements

"$CHRS Impressive Toripalimab Combo Rs ln Urothelial local & metastatic C w her2 expression Yet another example of this -PD1s potential in a broader program still selling for Amazingly😦 than cash plus 27% SI. Large($.93avg)position. ST PT+$3. Avg PT $5.7 💪Buy $XBI $IBB $CHRS https://t.co/YwP30ClLvY $CHRS https://t.co/YwP30ClLvY"
X Link 2025-10-20T15:35Z [----] followers, [----] engagements

"$NVCT Someone has decided to buy in here & theyre not too concerned about the priceIndicative of recognition there will be no tax loss selling & thereforeTime to start buying into runup into potentially monumental SolidTumor relevant Q2 [--] NXP-900 data $XBI $IBB"
X Link 2025-12-09T16:37Z [----] followers, [----] engagements

"Only Prob. w your thesis Dr is Dr Mato study showed 50-60% of IBR pts stop Tx due to AEs& even w mitigated TLS riskcombo will def. yield even more AE dropouts-IOWsNo picnic for 70/80% of pts in community Onc looking [--] safety & efficacy- $TGTX U2 combos the obv. Alt. GL:)"
X Link 2020-06-04T03:35Z [----] followers, [--] engagements

"$AXSM Narcolepsy BTD Should get some long overdue Firming/Price Appreciation since 3rd BTD suggests yet another(3rd)Impending NDA here.& as many have noted Consistently Flawless Execution only gets ignored for so long🥴:) $XBI $IBB"
X Link 2020-08-05T12:45Z [----] followers, [--] engagements

"$NVCT UpdateSince its clear theres no Tax Loss sellStock now building $7.50ish base at major ma200 resistance in anticipation of [----] Ascent/BO into confirmatory data. Volume slowed b/c over bought plus relatively few who appreciate already flush. Looking V.Solid $XBI $IBB $NVCT Someone has decided to buy in here & theyre not too concerned about the priceIndicative of recognition there will be no tax loss selling & thereforeTime to start buying into runup into potentially monumental SolidTumor relevant Q2 [--] NXP-900 data $XBI $IBB https://t.co/PVgPoLCPX6 $NVCT Someone has decided to buy in"
X Link 2025-12-17T15:27Z [----] followers, [----] engagements

"$CKPT As several of us have been saying amazing its still selling for a $315Ml(post pop)MC(@$4)🤦🏻♂.EV($255Ml).B.Riley is right Street imo just doesnt get it😏.yet-But w good cash & at least [--] multiBl seller they def will:) $XBI $IBB https://s2.q4cdn.com/326900168/files/doc_presentations/2021/05/Checkpoint-Presentation_CKPT_May-2021.pdf https://s2.q4cdn.com/326900168/files/doc_presentations/2021/05/Checkpoint-Presentation_CKPT_May-2021.pdf"
X Link 2021-06-09T12:05Z [----] followers, [--] engagements

"$NVAX vs $PFE/ $MRNA Whats most important to note/remember: In addition to safety/storage superiority NVAX💥100% efficacy in original strain(= Variants not of interest pop)that others did 95% efficacy in-Therefore overall a BIC product Winner going forward😅 $XBI $IBB $nvax whats important to remember is nvax encountered variants & was still over 90% effective. Im happy knowing I will be able to get a nvax booster shot in the US. $nvax whats important to remember is nvax encountered variants & was still over 90% effective. Im happy knowing I will be able to get a nvax booster shot in the US"
X Link 2021-06-14T13:41Z [----] followers, [--] engagements

"Against a [--] $VIX here are a Potpourri of biotechs that appear to have bottomed: $AXSM $MYOV $FBRX $FBIO $NVAX plus probably $OMER $CKPT & even(🤞)the $XBI 😅:)))"
X Link 2021-07-19T15:03Z [----] followers, [--] engagements

"Why Im not trading $XAIR.While multiple Lung Fit Resp. apps dont appear to be priced into the $300ml MC Unique MOA Multiple NO Onc apps Def. Arent🤦🏻♂ Therefore any reasonable POC in humans should warrant relatively quick 10x($💯)PT Large Strong Hold😅 $XBI $IBB"
X Link 2021-09-16T16:48Z [----] followers, [--] engagements

"$TGTX Impressive workshop on U2/V (ultra V)combos pot. to capture mult. linesincl. 1st L Txin CLL& potentiallyB-cell generallyon apparent BIC MRDneg. data in r/r(as good or better than comp studies in 1st line😅).Dr Furman stressed use best 1st&haltTx=Best Pt healing $XBI Watch Today: $TGTX is hosting an Investor & Analyst Virtual Event @ 8:30AM ET to discuss the investigational U2+Venetoclax data presented @ #iwCLL2021 & provide an overview of the ULTRA-V study. Watch: https://t.co/5RNBBuFZQf Details: https://t.co/LTZeaMI6bT #FearlessForPatients https://t.co/MXAvOYCdOS Watch Today: $TGTX is"
X Link 2021-09-20T14:36Z [----] followers, [--] engagements

"RE: $XAIR presentation.My Question: How many companies with multiple revolutionary technologies(LungFit NO Ventilator Systems & NO Oncology) trade for $250ml🤯 Prob.1 And if the second one pans out(as I firmly expect) all price targets are out the window😳💥🌞 $XBI Listen carefully to this $XAIR presentation. At the end the analyst host says the technology could be revolutionary. My question: how many revolutionary technologies trade for $250m Listen carefully to this $XAIR presentation. At the end the analyst host says the technology could be revolutionary. My question: how many"
X Link 2021-09-22T15:55Z [----] followers, [--] engagements

"$CKPT Todays Cantor was an ExtremelyStrongPresentation that confirmed & embellished upon all forward-looking guidanceAWA outlining a strong Mkting approach based on superior Efficacysafety & pricing.A top-five holding & Must listen for anyone interested in PDL space:) $XBI"
X Link 2021-09-27T14:04Z [----] followers, [--] engagements

"$XBI To All Holders(micros etc.)Have a Great Thanksgivingwhile we wait for various 🦃s to cure😅 My(always provisional) prediction is weve bottomed here. Seriously looks like a fake breakdown of the $118 support-Todays action on numerous fronts suggests as much:))) $IBB"
X Link 2021-11-24T17:13Z [----] followers, [--] engagements

"$TGTX & $ITCI Two💥Spots that are Buy/Holds here for dif Reasons-ITCIa powerful combination of Ext Need of BPD applus Buyout Potential=Uncanny [--] mnth Strength TGon the other handbeaten down to v.undervalued level-EV$1.58Blwhere MS alone worth min3-4Bl=Ext CheapBoth Solid"
X Link 2022-01-24T16:08Z [----] followers, [--] engagements

"$CKPT Though the initial rxn was UnderwhelmingMost desperate sellers/traders already out/crossing over to Investors on Def Approvable Tr results(Great effic.BIC Safety/Price) on Min downside/10x+upside for $200ml MC/60ml Cash Co w several assets in MultBl Mkts.Buy👻 $XBI"
X Link 2022-01-25T18:19Z [----] followers, [--] engagements

"$TGTX Update-Though I think U2(post ODAC) will be approved(June/July)if full Oncology=ed $0.00current EV(w/o even including 130ml Hercules cash still available)=900mlor a conservative 1/4to1/5 of totally approvable MSvalue.StrongBuy in Insane Biomarket Min 12m PT$40 $XBI"
X Link 2022-01-27T20:26Z [----] followers, [--] engagements

"$AXSM/ $SAGE Cant imagine anyone selecting Zuranolone adjunctive Tx for rapid efficacy which disappears in [--] days when AXS-05 shows Superior Impact in [--] wks that only improves over time🌞 (See pg9) $XBI $IBB https://axsometherapeuticsinc.gcs-web.com/static-files/d0beb034-c48d-45c2-8ac3-bfd85f26177f https://axsometherapeuticsinc.gcs-web.com/static-files/d0beb034-c48d-45c2-8ac3-bfd85f26177f"
X Link 2022-02-16T18:12Z [----] followers, [--] engagements

"$AXSM Seems people finally get the massive # of💎s clearly packaged w/in this CC-Via very compelling Maj Amendment timing logic(w/in context of no new FDA Qs to date)MDD should be approved 4-6wksfollowed by Migraine a few wks laterPlusHeavy Hitter P.Line close behind🌞 $XBI $AXSM - Axsome Therapeutics Inc.'s (AXSM) CEO Herriot Tabuteau on Q4 [----] Results - Earnings Call Transcript. https://t.co/YxwMUtRHUZ #finance #trading #markets $AXSM - Axsome Therapeutics Inc.'s (AXSM) CEO Herriot Tabuteau on Q4 [----] Results - Earnings Call Transcript. https://t.co/YxwMUtRHUZ #finance #trading #markets"
X Link 2022-03-01T18:06Z [----] followers, [--] engagements

"$AXSM @ Needham: Best & Most Informative presentation in recent memory. CEO exuded lots of positive energy suggesting a hi level of confidence on the cusp of so many Major Developments-Rare Listening Pleasure in a Must Listen CC🌞 $XBI $IBB https://wsw.com/webcast/needham118/register.aspxconf=needham118&page=axsm&url=https://wsw.com/webcast/needham118/axsm/2270700 https://wsw.com/webcast/needham118/register.aspxconf=needham118&page=axsm&url=https://wsw.com/webcast/needham118/axsm/2270700"
X Link 2022-03-16T15:11Z [----] followers, [--] engagements

"$AXSM Dont be fooled AXS-05 will be approved in Q2 as the Most Consequential MDD drug(in terms of speedefficacysuicidal ideation TRD)in decades.With Migraine BBuster kicker in days(plus massive PL)No One imo should be selling here.Guaranteedinstitutions wont be🌞 $XBI"
X Link 2022-04-19T12:51Z [----] followers, [--] engagements

"$AXSM Auvelity The new brand name for AXS-05. Needless to say wouldnt expect to see a disclosure like this unless the company was extremely confident:))) $XBI $IBB #Auvelity (#dextromethorphan + #bupropion) by #Axsome Therapeutics is new oral #antidepressant for #MajorDepressiveDisorder (#MDD). Rapid and long-acting Auvelity manages even the most severe #depression. $AXSM #clinicaldepression https://t.co/638cNqyzf3 #Auvelity (#dextromethorphan + #bupropion) by #Axsome Therapeutics is new oral #antidepressant for #MajorDepressiveDisorder (#MDD). Rapid and long-acting Auvelity manages even the"
X Link 2022-05-09T21:26Z [----] followers, [--] engagements

"$XBI Perspective & Near-Term Promise. $IBB https://www.marketwatch.com/story/the-capitulation-model-for-biotech-is-a-category-5-storm-the-same-as-energy-in-2020-why-contrarians-say-the-sector-is-a-buy-11653057284 https://www.marketwatch.com/story/the-capitulation-model-for-biotech-is-a-category-5-storm-the-same-as-energy-in-2020-why-contrarians-say-the-sector-is-a-buy-11653057284"
X Link 2022-05-23T22:47Z [----] followers, [--] engagements

"$XBI Bottoming/Stabilization-Though Ive learned(thru personal experience🥴)its Ext. Difficult to call bottoms$XBIs 90day chart suggests at least the formation of a bottoming range thatlike some other early entrant tech areasshould lead to outperformance going forward:) $IBB"
X Link 2022-06-22T15:51Z [----] followers, [--] engagements

"$AXSM This Low price vol. prob residual of general fear about biotech combined w people much more trading oriented-ST profits over a LT investment(even if were only talking a matter of weeks😉).Once traders exit(Soon)This will imo naturally rise to 40s-60s & beyond👻 $XBI"
X Link 2022-06-27T14:26Z [----] followers, [--] engagements

"$AXSM Update. Looks like institutions gave up on getting shares ultra cheap-Some big volume coming in here now-w [--] CNS drugs w overlapping pt populations & massive PL $5.5Bl MC $ITCI is now a rough comp- $AXSM Price Eq$143/share🌞 $$XBI $IBB"
X Link 2022-06-27T17:12Z [----] followers, [--] engagements

"$AXSM New SHARP Sunosi Cognitive Improvement datain addition to massively adding to Mkt superiority of current EDS/OSA indicationalso suggests odds of success in its next Maj.indication ADHD are that much greater. Imp.(largely unexpected) plus:) $XBI https://seekingalpha.com/news/3887857-axsm-stock-gains-as-sleep-disorder-therapy-increases-cognitive-function https://seekingalpha.com/news/3887857-axsm-stock-gains-as-sleep-disorder-therapy-increases-cognitive-function"
X Link 2022-10-03T13:51Z [----] followers, [--] engagements

"$TGTX MS Update-Had been out since the U2 collapse but I bought a sig. chunk at @ $9 avg on todays unassailably +/No Hype call. Expect quick ramp to $15 by early [----] or before(only 2Bl MC on MS assets easily worth 4-5Bl)& $20-$30 in [--] months. Truly Great r/r🌞 $XBI $IBB"
X Link 2022-12-29T17:10Z [----] followers, 22.6K engagements

"@cornel6m @Biotech2050 WADR I dont think $25 is nearly enough for an asset which is conservatively worth [--] to [--] BL.This is after all the state of the art cd [--] which is the current & likely future state of the art therapy for MS-couldnt therefore see $TGTX going for anything less than $40+"
X Link 2022-12-30T01:15Z [----] followers, [----] engagements

"$TGTX PrimeTime @ JPM Yes this is the first time I can remember them getting such a premier placement. $JPM as a major player in M&A/IB must believe some Major Partnerships &/or Acquisition must be in the offing & would like to get a piece of it.Nice Look🌞 $XBI $IBB @AndrewE_Dunn I think this is the first time $TGTX is presenting on the first day of JPM event and at an early time. Any thoughts @semodough @BillMiller32 #JPM23 @AndrewE_Dunn I think this is the first time $TGTX is presenting on the first day of JPM event and at an early time. Any thoughts @semodough @BillMiller32 #JPM23"
X Link 2023-01-09T03:39Z [----] followers, [----] engagements

"$TGTX Gap/Breakout $TGTX is well on its way(& for multiple reasons previously noted) to NT($15) PT & Way Way Beyond🎆 $XBI $IBB $TGTX MS Update-Had been out since the U2 collapse but I bought a sig. chunk at @ $9 avg on todays unassailably +/No Hype call. Expect quick ramp to $15 by early [----] or before(only 2Bl MC on MS assets easily worth 4-5Bl)& $20-$30 in [--] months. Truly Great r/r🌞 $XBI $IBB https://t.co/0wWMI8NPn9 $TGTX MS Update-Had been out since the U2 collapse but I bought a sig. chunk at @ $9 avg on todays unassailably +/No Hype call. Expect quick ramp to $15 by early [----] or"
X Link 2023-01-11T16:27Z [----] followers, 29.7K engagements

"$AXSM Truist Update Impressive Report. Definitely puts the lie to all the generic quibblings of $BAC & such. As they note theyre reworking their models(re:1Bl by 2034). Ill bet😀 With this kind of uniformly positive response profile [----] may be more appropriate:) $XBI $IBB Truist $AXSM BUY $150PT We polled [--] psychiatrists who have prescribed Auvelity since launch and overall feedback is highly positive. Based on positive initial real-world psychiatrist feedbacks we think Auvelity may outpace our sales forecast of $1BN by [----]. 1/ Truist $AXSM BUY $150PT We polled [--] psychiatrists who have"
X Link 2023-01-30T15:23Z [----] followers, 15.6K engagements

"$TGTX is definitely following the script now @ $15✅.but still imo a lot further to go here. GLTA:) $XBI $IBB $TGTX Gap/Breakout $TGTX is well on its way(& for multiple reasons previously noted) to NT($15) PT & Way Way Beyond🎆 $XBI $IBB $TGTX Gap/Breakout $TGTX is well on its way(& for multiple reasons previously noted) to NT($15) PT & Way Way Beyond🎆 $XBI $IBB"
X Link 2023-01-31T15:04Z [----] followers, [----] engagements

"$AXSM Veteran Affairs ContractThough theres been no obv.rxn in the marketplace its yet another telling data point in Auvelitys powerful adoption cyclewhich together w the sig National Epidemic in MDD only further validates its NearTerm Blockbuster Potential:) $XBI $IBB $AXSM Axsome Therapeutics has been awarded a five year Veterans Affairs federal supply schedule contract initially worth $28m. https://t.co/uJBXeNadic $AXSM Axsome Therapeutics has been awarded a five year Veterans Affairs federal supply schedule contract initially worth $28m. https://t.co/uJBXeNadic"
X Link 2023-02-01T17:36Z [----] followers, [----] engagements

"$AXSM SVB Call Though everyone seems(almost Myopically)focused on Auvelity #s & ADA NDA prospects(both coming along nicely)theres just so much more going on-Sunosi(+RXs#s & ADHD Tr starting v.soon)Narco Rs 1H23-NDAMigraine Q323 NDAFibro NDA eoy23.IOWs-Must Listen $XBI"
X Link 2023-02-15T14:59Z [----] followers, [----] engagements

"$AXSM Scripts.of course it was always going to be choppy(particularly in view of the holiday/seasonality issues) but the end should never have been in doubt😀 $XBI $IBB Signs of life returning to $AXSM script growth. https://t.co/EzyAC9UB10 Signs of life returning to $AXSM script growth. https://t.co/EzyAC9UB10"
X Link 2023-02-17T14:50Z [----] followers, [----] engagements

"Another V.SolidAlmost Encyclopedic $AXSM call(due to # of CNS/other addressed).Key Pts:1)Strong Auv. MDD growth in toughest lateLine pts=Early line Hi Vol still ahead2)10Bl Revs expd for all late stage meds-1/3 of that warrants5x cur. MC($350/sh).IOWs Still Way Undervalued:)"
X Link 2023-04-20T18:43Z [----] followers, 16.6K engagements

"$AXSM DropBig(mid-Wk dips)trading range continues in this skittish Mkt.But higher highs/lows ext.likely as trend(& RX #s)turn up& LT value only continues to build in this MassivelyUndervalued ClinicalStageBiopharma=💪Buy&Hold(w Trading on Margins)Pending MultNT Catalysts:) $XBI Another V.SolidAlmost Encyclopedic $AXSM call(due to # of CNS/other addressed).Key Pts:1)Strong Auv. MDD growth in toughest lateLine pts=Early line Hi Vol still ahead2)10Bl Revs expd for all late stage meds-1/3 of that warrants5x cur. MC($350/sh).IOWs Still Way Undervalued:) https://t.co/LedVIFJnKW Another"
X Link 2023-04-26T15:44Z [----] followers, 12.9K engagements

"$AXSM Scripts. Morgan Stanley(4-24-23)indicates yet another strong week(ending 4/21).3700=11% increase-At these rates of growth Cash Flow Positivity cant be far off:) $XBI $IBB"
X Link 2023-04-28T13:49Z [----] followers, [----] engagements

"$TGTX Just bought here in the $22.80s.Great LT value here imo:) $XBI"
X Link 2023-06-26T19:57Z [----] followers, [----] engagements

"$TGTX Just added10% to my position here.Think its unlikely to go much below $9.50-so so oversold & at strong support therefore new climb on any catalyst seems much more likely:))) $XBI $IBB"
X Link 2023-08-10T19:36Z [----] followers, [----] engagements

"$TGTX Bingo:))) $TGTX Just added10% to my position here.Think its unlikely to go much below $9.50-so so oversold & at strong support therefore new climb on any catalyst seems much more likely:))) $XBI $IBB $TGTX Just added10% to my position here.Think its unlikely to go much below $9.50-so so oversold & at strong support therefore new climb on any catalyst seems much more likely:))) $XBI $IBB"
X Link 2023-08-14T15:37Z [----] followers, [----] engagements

"$AXSM Rx #s up 7% per MS-Script data for the forty second full week of the Auvelity launch became available on 8/18. For the week ending Friday 8/11. IQVIA reported TRx of 4.9K for Auvelity (with Bloomberg reporting 5.3K). IQVIA scripts were up 7% vs. the prior week. $XBI $IBB"
X Link 2023-08-18T13:42Z [----] followers, [----] engagements

"$AXSM Rx Growth Trend.Whats obvious is w minimal media support to date Auvelity is on track to match most past MultiBl sellers w Massive Pharma ad & sales campaigns-Imagine future sales w incd reps & the multi media plan to come😀Plus maj PLJust getting started here $XBI"
X Link 2023-08-22T14:26Z [----] followers, [----] engagements

"$AXSM Q32023 Decent rev beat(57.8ml vs 55.75ml avg exp) during seasonally weak summer/fall period looking good particularly since this suggests $400-$500 Ml revenue run rate [----] confirming this Co w multiple NT catalysts at 3Bl MC/$417Ml 💰still way cheap😀:))) $XBI $IBB"
X Link 2023-11-06T14:55Z [----] followers, [----] engagements

"$AXSM Piper Sandler A very focused and coherent survey of product characteristics MOAs & commercial opportunities. Definitely worth a listen for all AXSM and serious CNS investors:) $XBI $IBB https://event.webcasts.com/starthere.jspei=1643618&tp_key=338aebde1a https://event.webcasts.com/starthere.jspei=1643618&tp_key=338aebde1a"
X Link 2023-11-28T15:17Z [----] followers, [----] engagements

"$AXSM could be looking to sell-But I think the plan is more or less what theyve been saying all along-Building & running integrated CNS midcap-look to be w/in yr or [--] of pulling that off-& what could be better for SH val IVO incd Rs & multiple BO/partner offers jmo:) $XBI $IBB $AXSM. On todays Piper Sandler fireside chat the biggest thing that stood out to me was an emphasis on "shareholder value". Haven't heard this as much on prior calls. Makes me wonder if they are waiting for a few more approvals before possibly selling the company. $AXSM. On todays Piper Sandler fireside chat the biggest"
X Link 2023-11-29T16:41Z [----] followers, [----] engagements

"$AXSM Why now Mgmt prob thought why unnecessarily torture shareholders w [--] more mnths of vol when they already had basic #s. At (conservatively) 400/500ml [----] net Revs def suggests no raise & at 8-10x net Rs w abundant catalysts a stock price surely on way up😀 $XBI $IBB"
X Link 2024-01-04T16:49Z [----] followers, 12.4K engagements

"$TGTX.Today's pop suggests Mike Weiss has positive things to say or he probably wouldn't have elected to participate in JPM(Tues Jan [--] 4:30pm). Seems like a reasonable assumption.:) $XBI $IBB"
X Link 2024-01-05T15:28Z [----] followers, 17.5K engagements

"$AXSM RBC Initiation-Outperform $126 cites Auvelity launch stable Cash flows from Sunosi & underappreciated PL Interesting & gratifying confirmation of what several LT holders have been saying all along😏. Another indication big developments are about to materialize:) $XBI"
X Link 2024-01-25T14:50Z [----] followers, [----] engagements

"$AXSM s rapid turnaround from hi $60s to $73+ in minutes suggests some big investors concluded theyd for lack of a better term run out of suckers to buy from down here👻Barring some maj unexpected bust I suspect weve essentially seen the bottom of this sequence. $XBI $IBB"
X Link 2024-03-11T18:50Z [----] followers, [----] engagements

"$AXSM LeerinkClarification of multiple issues: ADA on tract for Q4 Sunosi(in ADHD)Ph3 adult readout Q42024 Narcolepsy still Q1 [--] plus guidance for everything else(MigFibro smoking cess. binge eating & SWD) all confirmed-nice conversational reviewGood Listen✅ $XBI"
X Link 2024-03-13T14:54Z [----] followers, 12.9K engagements

"$AXSM Yes Symphony(Cataplexy) data ext. 💪 so why selloff Previous ext. 💪Ph2&3= Extra Expectation bias=strong Placebo Resp(typical in CNS) but ext. sig. curve sep. anyway proves AXS-12 potency-Mkt Rx Absurd esp. b/c not overbought. Even 💪er Buy on Another 💪asset:))) $XBI $AXSM my second largest biotech holding. This is an amazing data set lots to digest here. Conf call at 8am EST. https://t.co/YVOuDwP8Oa https://t.co/Q529dnDKNR $AXSM my second largest biotech holding. This is an amazing data set lots to digest here. Conf call at 8am EST. https://t.co/YVOuDwP8Oa https://t.co/Q529dnDKNR"
X Link 2024-03-25T15:54Z [----] followers, [----] engagements

"In other words Mkt & analysts will eventually catch up and appreciate singular value of AXS-12 as a proven cataplexy drg (separate from purenarcolepsy)& add yet another sig. asset to their $AXSM models. All part of ext broad CNS portfolio= Strong Buy:))) $XBI $IBB"
X Link 2024-03-25T16:06Z [----] followers, [----] engagements

"Positive Commentary re $AXSM ADA etc. Starts at [-----] min .Nice restatement of the obvious value & opportunity. $XBI $IBB https://www.biotechtv.com/post/mizuho-graig-suvannavejh-april-28-2024 https://www.biotechtv.com/post/mizuho-graig-suvannavejh-april-28-2024"
X Link 2024-04-19T14:33Z [----] followers, [----] engagements

"@_joebaffoe That sounds right to meJoe Only Q is how quickly the balance of market participants returned to net accumulation-Todays action seems to have provided fairly bullish clarification on that point(resuming upward drift post quick 1/2 retrace assuming it holds😅)is very Bullish:)"
X Link 2026-01-29T16:48Z [----] followers, [--] engagements

"Note- $TGTX GEN.SPA approval largely fait accompli at 200PtAnal; &w140+sitesprobably achieved early( $ASCO 6/16) https://twitter.com/tgtxdough/status/664034124143992832 https://twitter.com/tgtxdough/status/664034124143992832"
X Link 2015-11-10T17:57Z [----] followers, [--] engagements

"Assuming B -cell depletion is the MOAhere's all you need to know about why the $TGTX opportunity in MS is potent and real:-))) Sun Trust$28"
X Link 2017-05-09T16:20Z [----] followers, [--] engagements

"Today Mike Weiss Publically Outlined The Nature Of The Competitive Tx Landscape In CLL & NHL Plus Why & How It's Broadly Skewed In $TGTX's FavorJPM Pres. Highly Recommended:-))) - $XBI $IBB $CELG $ABBV $GILD $JNJ $BIIB $AMGN $AZN https://jpmorgan.metameetings.net/events/healthcare18/general_signin https://jpmorgan.metameetings.net/events/healthcare18/general_signin"
X Link 2018-01-11T16:21Z [----] followers, [--] engagements

"Better InfusionSafetyApprox [--] Relapses& MuchFewerLesions Not Enough $TGTX Ublitux. In MS(Vs Ocrel.)Showed Virtual Elimination Of CDP(DisabilityProgression@94%)Vs Mere CDP ReductionsPlusNEDA(74%)-A New MS Tx Standard In The Making $RHHBY $XBI $IBB $NVS"
X Link 2018-02-02T05:36Z [----] followers, [--] engagements

"$VSTM.High ORR & PFS w Massive Discontinuations(67%) & Multiple Serious Toxs(36% AES) Has Little Chance of Approval & Even Less of Any Sig.Mkt Share.A Scam $XBI $IBB $ALXN $CELG $BIIB $GILD $AZN $ABBV $TGTX http://verastem.com/wp-content/upl http://verastem.com/wp-content/upl"
X Link 2018-06-18T19:20Z [----] followers, [--] engagements

"William-A $TGTX Blockbuster Which is What I Expect Should Yield an Initial Stock Price of At Least $20.:-))) $XBI $IBB $ALXN $CELG $BIIB $GILD $AZN $ABBV $tgtx When the data is finally reported it will be: $tgtx When the data is finally reported it will be:"
X Link 2018-09-11T13:39Z [----] followers, [--] engagements

"$NVAV (vs $GSK / $SNY) When Glaxo etc. start rattling the cages about new additional vaccines far from threatening current producers it only underlines the Ext.Need that still exists.Advantage $NVAX:)))"
X Link 2021-05-19T17:04Z [----] followers, [--] engagements

"$AXSM Issue Particularly in this rate environmentMeasured Strategic Raise from position of strength to erase debt & build financial leverage to rapidly advance programs & empower them in any negotiations(partnerships acquisitionsetc.). Back to old lvls/beyond v.soon:) $XBI"
X Link 2023-06-28T13:55Z [----] followers, [----] engagements

"$AXSM And the winner is Capitulation of last [--] serious Auvelity objectors confirms it will be a multiBl product in MDD(& V.Prob ADAetc)laying groundwork for devel.of an aggressive high value CNS PL(plus others-e.g.Fibro).EventuallyEven $BAC couldnt ignore the obvious😆 $XBI"
X Link 2023-08-08T14:11Z [----] followers, [----] engagements

"Fed😆-On balanceChairmans commentary(measured restrictive) was basically expectedthus Mkt non-rxn.Though on balance I gen.dont endorse growth restricting measures to control inflation(prefer reduced regulatory pro growth approachs)Credit due [--] Rs/Consistency:) #Fed $XBI"
X Link 2023-08-25T16:28Z [----] followers, [--] engagements

"@cantilloncap @ShortShitStocks Or more probably less disinformation lol:)"
X Link 2024-01-04T17:02Z [----] followers, [---] engagements

"@technicalair Theres nothing approved in the mkt that services narcolepsy w cataplexy(Type1)well & that makes $AXSM AXS-12 v.approvable & potentially v.valuable since cataplexy is ext. debilitating & dangerously limits a patients range of safe activities.Why this Mkt Rx is imo so much BS🥴"
X Link 2024-03-25T19:38Z [----] followers, [---] engagements

"The $AXSM prospect of [--] almost certainly approvable filings w/in days(Migraine & Fibro) likely leading to [--] approved drugs by Q1 [--] added to 💪 Auvelity Ramp def.seems to have firmed up this chartimo Sig.🚀 set up up near term:))) $XBI $IBB"
X Link 2024-06-27T16:58Z [----] followers, [----] engagements

"$AXSM/AXS-07 New research suggests $AXSM Triptan-based migraine drug should be favored over others b/c Trips are more effective. The added [--] meloxicam kicker will make it preferred due to sig increased speed & durability. Time to boost [--] models😀 $XBI https://dgnews.docguide.com/article/triptans-more-effective-than-newer-migraine-drugs https://dgnews.docguide.com/article/triptans-more-effective-than-newer-migraine-drugs"
X Link 2024-09-20T17:17Z [----] followers, [----] engagements

"Would add just as Auvelity w a different/superior moa (vs SSRIs)is proving to be a 1st line go to in MDDso AXS-07 w a different/More powerful delivery mech.will quickly come to be appreciated as the preferred Migraine Tx. Just another notch in $AXSMs CNS playbook✅ $XBI"
X Link 2024-09-20T18:17Z [----] followers, [----] engagements

"$AXSM/AXS-07 update-Since Pfizer paid 11.6Bl in [----] for Biohavens cgrp thats clearly inferior to trips for acute )& [--] is superior to Trips Contrary to just another Mig. drgnotions [--] def. should/will be a Multi-Bl BlockBuster💥 $XBI $IBB http://mdlinx.com/news/expensive @BillMiller32 Rizatriptan's data was [--] of the best for acute migraine so note [--] achieved pain relief than rizatriptan at every time point measured starting at [--] minutes & was sig stat vs Riza at 1hr (p=0.04). 07's % with pain relief at [---] hours after dosing was 60.5% vs 52.5% for Riza http://mdlinx.com/news/expensive"
X Link 2024-09-23T19:45Z [----] followers, [----] engagements

"AXSM Q3Though I planned to sell some at $100wont b/c of solid Rev plus So So many NT setups😍: ADA RsFibro NDA & Narc Rs(Q4) & Migraine ApprovalADHD & MDD ph3s(solriamfetol)Q1/25 make this a Great Q💥Esp. in context of safe/low LT cap gains=$100+ base V.V.Soon😀 $XBI"
X Link 2024-11-12T16:19Z [----] followers, [----] engagements

"Biotech Selloff Really way overdone in COs like $AXSM & $TGTXwhich get drug approvals DESPITE the big Pharma/FDA Cabalalready have significant growing Rev. Streams& pipelines of really needed drugs that big Pharma will need during its vaccine/Glp1 drought🤢 Buy😍 $XBI $IBB"
X Link 2024-11-15T19:31Z [----] followers, [----] engagements

"Vibes today suggesting + $AXSM ADA Rs next week Who knows but its definitely coming soon & the market seems to be sniffing it out-One of many positive things to come here Near TermBuy😍 $XBI $IBB"
X Link 2024-11-21T20:38Z [----] followers, [----] engagements

"$AXSM Narcolepsy Non-Rxn Since Narco is obv an in the bag slam dunkesp. w Crit. much needed Cataplexy app.should be 7-10% popbut shadow of ADA Rs clearly holding it back-Irony is w/o ADA wed see +7-10%.Howeverdespite mkt cautionstill v.confident in major ADA Rs NT:-) $XBI $AXSM Positive Ph3 AXS-12 (reboxetine) trial in narcolepsy https://t.co/c2TovYAZUU https://t.co/WCOh8a0SnJ $AXSM Positive Ph3 AXS-12 (reboxetine) trial in narcolepsy https://t.co/c2TovYAZUU https://t.co/WCOh8a0SnJ"
X Link 2024-11-26T16:23Z [----] followers, [----] engagements

"ConciseRel. ConservativeSummary of $AXSM NT Prospects. Multiple Emerging 💪s & Rev streams w/in largely integrated CNS Portfolio-Why 97+% Float held by [---] Institutionsw No Sig. InsiderSales(10Yrs)is on cusp of $150 share price & Still By V.Farmy largest position😍 $XBI @7SkiesTech @JD4for4 $AXSM By Jan 31st [--] gets FDA migraine approval & [--] will be 4/4 in ADA P3s. By end of 2Q/25 & ADA sNDA submitted to FDA & Auvelity's MDD sales will be on a $500m rate for [----]. If any of [--] Sunosi P3s indications hit it turns a small drug into a $1B drug. AXSM's sp will be $150. @7SkiesTech @JD4for4 $AXSM"
X Link 2024-12-10T17:13Z [----] followers, [----] engagements

"My feelings exactly So many bios get tax loss sold almost every year(= $XBI etc.) that virtues of specific COs get obscuredwhile minor risks in the context of overall value get absurdly magnified $AXSM is def. a case in point. Thus any ADA hiccup would be a maj op😍 $IBB $AXSM not sure how PH3 data will be for Alzheimer's related Agitation but any pullback will be a good opportunity $AXSM not sure how PH3 data will be for Alzheimer's related Agitation but any pullback will be a good opportunity"
X Link 2024-12-13T19:46Z [----] followers, [----] engagements

"Would add howeverthat though I expect ADA ph3 Rs will be successfulits precisely the minor risk they wont thats been blown out of proportion(particularly in the context of the overall program value of $AXSM)that together w $XBI pressure is causing the selling.Thus the op:-)"
X Link 2024-12-13T19:57Z [----] followers, [---] engagements

"Re $AXSM-Nice Work mike g.-yesterdays update unequivocally confirms ADV2 Rs by 12/24thisimo assures clarification of what I believe will be successful AXS-05 ADA TRs litterally any day now but certainly before Jan2025as per earlier guidance:-) $XBI http://clinicaltrials.org $AXSM WAG is we get ADV2 ACC2 & OLS on Mon AM ADVANCE-2 was updated today 12-19-24 by Clinical to "Active not recruiting". A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation ADVANCE2 https://t.co/KExTQdgLs8 Cli http://clinicaltrials.org $AXSM WAG is we get ADV2 ACC2 & OLS on"
X Link 2024-12-20T15:47Z [----] followers, [----] engagements

"$NVCT Have continued to accumulate sig shares during obv tax loss selling washout period(basically over)-Now by far my 2nd largest position anticipating [----] up repricing prior to data updates. Favorable r/r here seems undeniable imo-Regards all😍 $XBI $IBB Top-3 $NVCT investors who ready own [--] million shares or 38% stake bought about [-----] shares below $5 in recent weeks. When you already own that many shares small purchases dont mean a lot on the numbers but sure have a lot of meaning in display of confidence in outlook. https://t.co/MmJmylIyYm Top-3 $NVCT investors who ready own 73"
X Link 2024-12-26T16:38Z [----] followers, [----] engagements

"By the way regarding $NVCT Mgmts alignment with Avg shareholder interests I 💕 this statisticAlong w very low burn rates & a min dilution regime much like the case w early $AXSM these are classic signs of Mgmt confidence & integrity-Absolutely Love❤it:-) $XBI $IBB"
X Link 2024-12-26T20:12Z [----] followers, [----] engagements

"I believe $AXSM [--] will definitely be approved in ADA b/c ext need & safety(the reasons for BTD) are still operative issues w only BlackBox atypical antipsychotics as alternative TXs. IOWs IVO the totality of ext positive evidence the case is imo v.clear:-) $XBI $IBB $AXSM Alzheimer's data was the catalyst I wasn't sure how it will pan out. It's in the hindsight now. Dips will be good buyop in this company $AXSM Alzheimer's data was the catalyst I wasn't sure how it will pan out. It's in the hindsight now. Dips will be good buyop in this company"
X Link 2025-01-06T05:42Z [----] followers, [----] engagements

"$AXSM WakeUp $ITCI acquisition & Q4/Full yr pre-announcement plus Imminent Migaine Approval has refocused Institutional AttentionReally have to wonder what took so long😦 $XBI $IBB $axsm Truist Financial from $150.00 to $180.00 in a report released on MondayBenzinga reports. $axsm Truist Financial from $150.00 to $180.00 in a report released on MondayBenzinga reports"
X Link 2025-01-13T16:13Z [----] followers, [----] engagements

"Todays $GSK Purchase of IDRx showcases exactly the type of early stage high value targeted Oncology assets that $NVCT possesses & big pharma is hungry forthe spotlight here cant be very far $XBI $IBB https://finance.yahoo.com/news/jp-morgan-2025-gsk-acquires-122418800.html https://finance.yahoo.com/news/jp-morgan-2025-gsk-acquires-122418800.html"
X Link 2025-01-13T17:01Z [----] followers, [----] engagements

"@Pharmdca One of the only and probably the best-but I just dont think $AXSM is particularly interested in selling at this level when there are so many additional product catalysts yet to unfold-of course if they didit would only be for much higher multiple than most-$250-$300min:-) $XBI"
X Link 2025-01-15T17:25Z [----] followers, [----] engagements

"🙏 Pharmdca-Imagine you also agree just because $AXSM not likely to experience immediate takeoverstill a great hold for run up to $200+ when its likely-Many(takeout focused)forget $ITCI in hi $40s little over a yr agoup100% pre-takeout-lot of ult.value in run ups:-) $XBI @BillMiller32 agree Bill @BillMiller32 agree Bill"
X Link 2025-01-16T15:43Z [----] followers, [----] engagements

"$AXSM setup to BreakOut from last resistance on AXS-07(Migraine) approval w/in daysMarket is saying(as many of us have)that this is a Ext.Positive Done-Deal💥:))) $XBI $IBB"
X Link 2025-01-22T19:46Z [----] followers, 12K engagements

"$AXSM ($131MC6.4Bl) $ITCI ($127MC13.5Bl)With (pro acquisition)asset validation of patent settlementa lot of parallelsbut w ADHD on board also a whole lot of room to run hereContinue to hold 96% of massive positionReally like r/r of this particular dice 🎲 roll😍 $XBI"
X Link 2025-02-10T17:27Z [----] followers, 18.9K engagements

"$AXSM today clarified why SYMBRAVO is superior to cgrps & why it will contrary to most market analysts be another BIC Bl$ BB added to their CNS stable of $XBI $IBB https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-symbravor-meloxicam-and $AXSM/AXS-07 update-Since Pfizer paid 11.6Bl in [----] for Biohavens cgrp thats clearly inferior to trips for acute mig.(https://t.co/pFq5yXO4kT )& [--] is superior to Trips Contrary to just another Mig. drgnotions [--] def. should/will be a Multi-Bl BlockBuster💥 $XBI $IBB"
X Link 2025-02-24T14:55Z [----] followers, 11.6K engagements

"$AXSM ParadoxExt. steep [----] fundamentals-based growth trajectoryin context of a particularly weak Biotech sectorplus Ext overbought conditionhave created Sig Volatility swimming against the tide-But positive direction still clear b/c Massively Undervalued-Buy💥 $XBI $IBB"
X Link 2025-02-24T16:43Z [----] followers, [----] engagements

"@Biomaven Hi Peter-Re $TGTX I may be missing something but I would say that the extent and frequency of that myopia makes the market anything but efficient although I strongly agree with your strategy in terms of how to cope with it😆Cheers:-)"
X Link 2025-03-03T17:45Z [----] followers, [---] engagements

"@Biomaven Or IOWs the Mkt is almost always focused on ST quarterly earnings often based upon previous patterns of performance that are about to be undercut & disproven by superior technologies-doesnt seem to be anything efficient about that😦btw glad youre still posting:-)"
X Link 2025-03-03T18:05Z [----] followers, [---] engagements

"$AXSM ADHD Rs Much like initial neg. Mkt response to less than perfect ADA TRs analysts & Mkt will soon acknowledge Soli. will be approved as only safe effective(Lvl4 alt to dangerous stimulants)in ADHD. Therefore Today & any further erosion is imo a buying op:-) $XBI $IBB"
X Link 2025-03-25T18:27Z [----] followers, [----] engagements

"@zipjet TAM is a big+for $TGTX partic. from such a low lvl of penetration.But $AXSM has a very large collective TAM as well.And yesBriumvi should def. get traction in auto immune-but thats probably a ways off. However re mgmt quality & hist. integrity I have to give the nod to $AXSM"
X Link 2025-04-03T15:02Z [----] followers, [----] engagements

"@GeertLangenus Mixed feelings on that score-but they (CEO and management team) are relatively young so if they do sell it would only be for a hefty premium"
X Link 2025-04-25T22:17Z [----] followers, [--] engagements

"$AXSM 5-23-25 RXs Up a few % points in todays most recent report-Part of the solid and consistent growth trend presented"
X Link 2025-05-23T19:44Z [----] followers, [----] engagements

"@technicalair Thanks Paul-Sadly with the advent of so many hot🤓alternative risk-orientated investmentsthe fundamental LT growth value of even the best COs like $AXSM has at least temporarily been put on hold until they get rediscovered& everyone will be asking how did we miss it😆 $XBI"
X Link 2025-07-24T15:19Z [----] followers, [----] engagements

"Looks like this $PRGO/ $MYL thing has sparked the $AACR / $ASCO run- $TGTX $CEMP etc.so much tinder just waiting to be set aflame:-)))"
X Link 2015-04-08T19:56Z [----] followers, [--] engagements

"3rd retest of 3mth $XBI 210/230 channel in progressw $ASCO $EHA $Lugano imminent BO above [---] predicted=s plus $TGTX $CEMP $KPTI $TRIL etc"
X Link 2015-05-21T16:46Z [----] followers, [--] engagements

"Against backdrop of $ALNY $TGTX meds that much more attractivewhere tx safety (in addition to superior efficacy & combo pricing)paramount https://x.com/tgtxdough/status/784002011121319936 @Liquid_Biopsy_ $TGTX expect 3-4% liver toxicity rate (TG-1303) appear significantly favorable to the 30% control toxicity. BEST IN CLASS https://x.com/tgtxdough/status/784002011121319936 @Liquid_Biopsy_ $TGTX expect 3-4% liver toxicity rate (TG-1303) appear significantly favorable to the 30% control toxicity. BEST IN CLASS"
X Link 2016-10-06T14:18Z [----] followers, [--] engagements

"$TGTX Christmas Rally Starting To Rumble.Signs of A New Year In More Ways Than One:-))) $XBI $IBB $KITE $JUNO $ABBV $BIIB $CELG $GILD"
X Link 2017-12-28T19:33Z [----] followers, [--] engagements

"Is This It Or Just The Signal.Clearly The Latter:-))) $TGTX Umbralisib in Unity CLL & NHL(DLBCL)Expansion Cohorts Will Transform B-cell Onc. Tx.Add in Ublituximab in MS And You Know We're Just Getting Started Here $XBI $IBB $ABBV $CELG $GILD $BIIB $AZN $AMGN $RHHBY $NVS"
X Link 2018-02-21T19:22Z [----] followers, [--] engagements

"$TGTX.Another Day Of Obvious Outperformance In The Face Of Turmoil.Just Waiting For Multiple Confirmations Near At Hand:-))) $XBI $IBB $ABBV $CELG $GILD $BIIB $AZN $AMGN $RHHBY $NVS"
X Link 2018-03-01T19:38Z [----] followers, [--] engagements

"$TGTX's Mike Weiss Sounded Appropriately Excited & Confident Today.No Surprise There:-))) A Great Listen.wsw.com/webcast/rj108/ $XBI $IBB $ABBV $CELG $GILD $BIIB $AZN $AMGN $RHHBY $NVS"
X Link 2018-03-06T20:51Z [----] followers, [--] engagements

"$Omer Prospects of Imminent BLA Just Too Compelling-Therefore Building Post-Pop Base As $20s/$30s Squeeze Continues $XBI $IBB $ALXN $CELG $BIIB $GILD $AZN"
X Link 2018-05-11T16:26Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing